Printer Friendly

1,250,000 THERATECH, INC. COMMON SHARES OFFERED AT $14.00 PER SHARE

 SALT LAKE CITY, Dec. 18 /PRNewswire/ -- TheraTech, Inc. (NASDAQ-NMS: THRT), announced today the public offering of 1,250,000 shares of common stock at $14.00 per share. All of the shares are being sold by the company. William Blair & Company and Vector Securities International, Inc., co-managed the underwriting group. The company has granted the underwriters a 30-day option to purchase up to an additional 187,500 common shares to cover over-allotments, if any.
 Net proceeds to the company will be used to fund research and development activities, construction of additional facilities, purchases of equipment, and for working capital and general corporate purposes.
 Headquartered in Salt Lake City, TheraTech, Inc. develops advanced, controlled release drug delivery products which administer drugs through the skin, by oral delivery to the gastrointestinal tract, through tissues in the mouth and by other means. TheraTech currently has five drug delivery products in clinical development ranging from Phase I to Phase III, six products in preclinical development and seven products in earlier stages of development.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful under the securities laws of any such state.
 -0- 12/18/92
 /CONTACT: Steven C. Mayer or Myrna Duncan of TheraTech, 801-583-6028; Mark J. Brand of Pondel Parsons & Wilkinson, 301-207-9300, for TheraTech; or Mark A. Timmerman of William Blair & Company, 312-236-1600/
 (THRT)


CO: TheraTech, Inc. ST: Utah IN: MTC SU: OFR

GK-LR -- NY027 -- 8135 12/18/92 10:39 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 18, 1992
Words:269
Previous Article:DIAMOND SHAMROCK TO ACQUIRE 15 VICKERS STORES IN NEW MEXICO
Next Article:UNDERWRITERS ANNOUNCE PUBLIC OFFERING OF LINCARE HOLDINGS INC. COMMON STOCK AT $28.50 PER SHARE
Topics:


Related Articles
THERATECH FILES INITIAL PUBLIC OFFERING OF 2,000,000 COMMON SHARES WITH SEC
THERATECH ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK
THERATECH, INC. FILES PUBLIC OFFERING OF 1,250,000 COMMON SHARES WITH SEC
COLUMBIA BANKING SYSTEM INC. ANNOUNCES PROPOSED COMMON STOCK OFFERING
COLUMBIA BANKING SYSTEM INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
NOVA ANNOUNCES FINANCING AGREEMENT
APROGENEX, INC. COMPLETES INITIAL PUBLIC OFFERING
CITIZENS SECURITY GROUP INC. ANNOUNCES STOCK EXCHANGE
BIOBOTTOMS INC. GOING PUBLIC
/C O R R E C T I O N -- Watson Pharmaceuticals, Inc./.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters